miR-7 is preferentially expressed in neuroendocrine tissues, specifically the and pancreas .
: Recent studies highlight its role in regulating immune responses, including T-cell activation and neuroinflammation. Clinical Potential Due to its broad regulatory reach, miR-7 is a target for:
MicroRNA-7 is a highly conserved, non-coding RNA molecule approximately 22 nucleotides long. In humans, the mature miR-7 sequence is generated from three distinct genomic loci: (Chromosome 9), MIR7-2 (Chromosome 15), and MIR7-3 (Chromosome 19). It is primarily recognized as a "network stabilizer" that maintains cellular homeostasis under environmental stress. Biological Functions and Regulation Mirna.7z
: Restoring miR-7 levels through "mimics" is being explored as an adjuvant therapy to sensitize cancer cells to chemotherapy and overcome multidrug resistance.
The dysregulation of miR-7 is a hallmark of several major pathologies: In humans, the mature miR-7 sequence is generated
: In the pancreas, it is the most abundant endocrine miRNA in islets, where it acts as a "brake" on adult beta-cell proliferation and helps regulate insulin secretion.
: In Parkinson’s disease , miR-7 levels are typically decreased, leading to the toxic accumulation of α-synuclein . Conversely, its levels are often upregulated in Alzheimer’s disease and schizophrenia. The dysregulation of miR-7 is a hallmark of
: It regulates the development of the pituitary gland, optic nervous system, and cerebral cortex by targeting factors like PAX6 , which is essential for eye and brain organogenesis.